Terns Pharmaceuticals Inc (TERN) - Tingkat bathi reged

Simbol resmi perusahaan Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals is optimizing supply chains for gastrointestinal research while developing an oral GLP-1 analogue within the obesity segment. Gross margin fluctuations on GURU.Markets reflect production efficiency, with the 0.00 metric confirming current levels. The company's strategy relies on long-term scaling and the accelerated progression of clinical trials for new metabolic molecules.

ternspharma.com - Margin reged TERN (periode 04.07.2022 - 16.05.2026)

Rincian analitis lan laporan data perusahaan Terns Pharmaceuticals (TERN)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:TERN, Terns Pharmaceuticals, Inc.
Produk asil prodhuksi Terns Corp

Terns Pharmaceuticals (TERN) operates in the high-risk obesity segment, where gross margin volatility reflects the effectiveness of direct cost management for the development of oral medications. This indicator measures the portion of revenue remaining after deducting the cost of goods sold, allowing investors to assess the actual profitability of the business and the resilience of patents prior to receiving final clinical phase data.